Management of uncomplicated malaria in private health facilities in North-West Ethiopia: a clinical audit of current practices by Argaw, Mesele D et al.
RESEARCH ARTICLE Open Access
Management of uncomplicated malaria in
private health facilities in North-West
Ethiopia: a clinical audit of current practices
Mesele Damte Argaw1,2* , Thandisizwe Redford Mavundla2 and Kassa Daka Gidebo3
Abstract
Background: Malaria is one of the leading public health problems in sub-Saharan Africa that contributes to
significant patient morbidity and mortality. The aim of the study was to investigate adherence to malaria diagnosis
and treatment guidelines by private health sector providers and compare their performance against the public
private partnership (PPP) status.
Methods: A facility-based retrospective clinical audit was conducted between October 2016 and January 2017 in
11 medium clinics in the West Gojjam zone of the Amhara Region, North-west Ethiopia. Data was extracted from
patient medical records using pretested data abstraction forms. Descriptive statistics were employed to present the
findings and adherence of health workers against the national and international standards were classified as ideal,
acceptable, minor error and major error for both malaria diagnosis and treatment. A chi-square (X2) test was used to
test for a statistically significant relationship after the data had been categorized using public private partnership
status at P < 0.05.
Results: One thousand six hundred fifty clinical files were audited. All malaria suspected patients were investigated
either with microscopy or rapid diagnostics test (RDT) for parasitological confirmation. The proportion of malaria
treated cases was 23.7% (391/1650). Of which 16.6% (274/1650) were uncomplicated, 3.69% (61 /1650) were severe
and complicated and the rest 3.39% (56/1650) were clinical diagnosed malaria cases. And the malaria parasite
positivity rate was 20.30% (335/1650). All malaria suspected patients were not investigated with ideal malaria
diagnosis recommendations; only 19.4% (320/1650) were investigated with acceptable malaria diagnosis (public
private partnership (PPP) 19.4%; 176/907; and non-public private partnership (NPPP) 19.38%; 144/743, X2 (1) =
0.0With regards to treatments of malaria cases, the majority 82.9% of Plasmodium vivax cases were managed with
ideal recommended treatment (X2 (1) = 0.35, P = 0.55); among Plasmodium falciparum, mixed (Plasmodium
falciparum and Plasmodium vivax).
Conclusion: The clinical audit revealed that the majority of malaria patients had received minor error malaria
diagnostic services. In addition, only one fifth of malaria patients had received ideal malaria treatment services. To
understand the reasons for the low levels of malaria diagnosis and treatment adherence with national guidelines, a
qualitative exploratory descriptive study is recommended.
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Background
In the last two decades, substantial progress has been
made in fighting malaria [1]. According to the latest esti-
mates of the World Health Organization (WHO), the in-
cidence of malaria was reduced by 41% and the rate of
malaria-associated deaths was reduced by 62% globally,
between 2000 and 2015 [2]. However, at the beginning
of 2016, malaria was still considered to be endemic in 91
countries and territories. Approximately 212 million
cases of malaria and 429,000 deaths associated with mal-
aria were reported in 2015 alone [2]. Malaria is prevalent
in 75% of the 1.1 million square kilometre land mass of
Ethiopia and affects over 60% of the Ethiopian popula-
tion [3], which was estimated at 99 million in 2015 [4].
Globally, prompt and effective diagnosis and treatment
of uncomplicated malaria cases has been implemented
for several decades. This makes it possible for patients
to be cured timely, preventing the development of severe
malaria and subsequent death [5–8]. The current na-
tional malaria diagnosis guidelines recommend that
every suspected case of malaria must be confirmed ei-
ther by microscopy or by a rapid diagnostic test (RDT)
before treatment is initiated [7–10]. Hence, anti-malarial
drugs are prescribed only for confirmed cases. However,
in areas where parasite-based diagnostic testing is not
available, malaria treatment is initiated solely based on
clinical suspicion. Therefore, parasitological confirm-
ation is believed to improve the overall management of
febrile illnesses [7].
The international and national malaria treatment protocols
recommend treatment with species-specific anti-malarial
drugs. The first-line recommendations for uncomplicated
malaria include artemether-lumefantrine (AL), at a total dose
of 5–24mg/kg body weight (BW) of artemether and 29–
144mg/kg of lumefantrine plus 0.25mg/kg BW single low-
dose (SLD) primaquine, and chloroquine 25mg/kg BW for
the treatment of Plasmodium falciparum and Plasmodium
vivaxmalaria, respectively. The second-line recommendation
consist of quinine plus SLD primaquine for the treatment of
uncomplicated P. falciparum or mixed or presumed malaria
infection, and AL for the treatment of uncomplicated P.
vivax malaria. No antibiotics are recommended for malaria
case management in Ethiopia [7, 11]. Unlike the 2015 WHO
treatment guidelines, Ethiopian malaria guidelines recom-
mended radical cure of P. vivax malaria cases using prima-
quine 0.25mg/kg BW/day for 14 days to be administered
under health workers’ supervision only in malaria elimin-
ation target districts [11] (Fig. 1).
According to the third National Malaria Indicator Sur-
vey (EMIS 2015), close to one-fifth of malaria cases in
Ethiopia were diagnosed and treated in formal private
health facilities [12]. Among the ten zones of the Am-
hara Region, the West Gojjam Zone contributed the sec-
ond largest number of malaria cases in the year 2013
[13]. Based on the routine health management informa-
tion system (HMIS) report [14], there were about
14.01% (104,202/743,851) confirmed cases of malaria in
1 year, that is, July 2013 – June 2014 [15].
Effective malaria case management in both private and
public health facilities will not only improve individual-
centred care, but also prevents the transmission of diseases
in the community and the emergence of ACT-resistant par-
asites [16, 17]. Accordingly, it is necessary to conduct a
clinical audit of practices of actual case management of
malaria in health facilities in comparison with the national
and international standards.
In Ethiopia, public-private partnership approaches for
malaria care services have been implemented since 2012
[18]. During the last 6 years, the PPM for malaria care
service initiated with 39 private health facilities and the
number of partner private health facilities reached 210
in 2016 [19]. The public health sector and public private
partner facilities are part of quality assurance interven-
tions which includes clinical audit, External Quality As-
surance (EQA) scheme. Conducting operational research
helps fill the information gap. This allows the public sec-
tor and the private health facilities to use the informa-
tion to improve governance and stewardship to scale up
the initiative so as to ensure access to quality and equity
of malaria care.
The purpose of this clinical audit was to determine the
adherence to standard malaria diagnosis and treatment
guidelines by private health providers and compare re-
sults by partnership status among facilities located in the
West Gojjam Zone of the Amhara regional state in the
north-west of Ethiopia. Furthermore, the results of the
study will be used to inform targeted interventions to
improve the quality of outpatient malaria case manage-
ment in the private health sector in Ethiopia.
Methods
Design of the study
A facility based retrospective study design was con-
ducted through a clinical audit [20] of the diagnosis and
treatment of uncomplicated malaria cases who were
served in 11 medium clinics located in the West Gojjam
Zone, Amhara, Ethiopia, between October 2016 and
January 2017. This study period was selected for high
malaria transmission season in the study areas.
Setting of the study
The West Gojjam Zone is one of the ten administrative
zones of the Amhara regional state. Based on the national
census [21] (2007), the projected population of the West
Gojjam Zone for 2017 was 2.2 million (www.CSA.gov.et).
Four woredas (districts), namely, Finote Selam, Jabih
Tehina, Bure and Wenberma were selected based on the
reported high incidence of malaria cases. In West Gojjam
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zone health services are provided by one hospital, 90
health centres, 363 health posts and 76 private health fa-
cilities [15]. The clinical audit was carried out on patient
medical records of 11 private for-profit medium clinics in
the zone. All of the clinics sampled are established as pri-
vate for-profit facilities, but 6 of the 11 facilities were
working in public–private partnerships (PPPs) for malaria
care services in terms of which partner facilities had access
to anti-malarial supplies and received technical support
from the public health sector [19].
Population
The target population for this study was included of adults
above 18 years of age who had been beneficiaries of malaria
services in the targeted 11 medium clinics in the 3 months
preceding the clinical audit. Only adults diagnosed and
treated for uncomplicated malaria were included in this clin-
ical audit. Since this clinical audit was conducted to explore
the clinical practice and synthesize the information to de-
velop an in-depth interview guide for qualitative research,
patients under the age of 18 years, patients diagnosed with
and treated for severe and complicated malaria, and patients
with two or more diagnoses were excluded from the study.
Sampling methods
The West Gojjam zone was selected through purposive
sampling for its accessibility from the main road and
convenience for the researchers. However, the woredas,
Fig. 1 Algorism used to analyses adherence of health workers with the national & international standards, West Gojjam, Ethiopia, Oct 2016- Jan
2017. The figure clearly depicted the algorism of malaria diagnosis and treatment as stated in international national standards guidelines
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the smallest administrative structures equivalent to dis-
tricts, were selected based on the high burden of malaria.
In 2012, the incidence of malaria in the selected four
woredas ranged from 40 to over 100 per 1000 population
[13]. All eleven medium clinics were enrolled in the
study. Clinical records of patients with uncomplicated
malaria were audited. The reviews were conducted in re-
spect of the preceding three-month period. In each se-
lected facility, all clinical files which fulfil the inclusion
criteria were reviewed.
Data collection tools and data quality
The data collection tools for the clinical audit were devel-
oped from the national and international malaria diagnosis
and treatment guidelines [7, 8]. The tools developed for
data collection were pretested using 30 clinical records of
uncomplicated malaria in adult patients. Trained public
health specialists, nurses and laboratory technologists were
responsible for data extractions. In addition, one of the
principal researchers supervised the day-to-day activities
and ensured the consistency, completeness and quality of
collected data.
Extracted data
The data extracted from patient medical records and out-
patient facility registers were used for this study. The data el-
ements collected include: initial or follow-up visit; patient’s
age, gender and weight; temperature; chief complaints; clin-
ical features; methods of diagnosis; diagnostic tests; parasite
load; and anti-malarial drugs prescribed and administered.
The diagnosis and treatment criteria adopted for the clinical
audit were proofed as “Yes”, “No”, or “Not applicable” as
documented in the medical records. Methods of diagnosis
were judged based on the findings “parasitologically con-
firmed using microscope”, “parasitologically confirmed using
RDT” and “presumed malaria cases”. The laboratory investi-
gation results, “P. falciparum malaria”, “P. vivax malaria”
and “mixed infection (P. falciparum + P. vivax malaria)”,
were extracted as documented in patient charts. Patient re-
cords with clinical and laboratory evidence of severe malaria,
such as coma, severe malarial anaemia (haemoglobin or
haematocrit), hypoglycaemia, circulatory collapse, renal fail-
ure (haemoglobin urea and creatinine), pulmonary oedema,
spontaneous bleeding, repeated convulsions, acidosis,
haemoglobinuria, impaired consciousness, jaundice, prostra-
tion, hyperpyrexia and hyperparasitaemia were excluded
from the reviews for this study [7, 10].
For this study, medical records of 1650 adult outpa-
tients who had received malaria services were audited in
11 medium private clinics. A clinical audit was systemat-
ically performed using selected information of patients
who had received malaria services within the preceding
3 months (i.e. October 2016 – January 2017).
Data analysis
Data entry and cleaning was conducted using Microsoft
Excel 2010. For the statistical analysis, the cleaned data
were exported to the Statistical Package for the Social
Sciences (SPSS) (IBM-SPSS version 20). The descriptive
results were presented using tables and graphs [22]. For
categorical variables, a chi-square (X2) test was
employed to test for a statistically significant relation-
ship, which was claimed at P < 0.05.
Ethical clearance
Ethical clearance was obtained from the Health Studies
Higher Degrees Committee (HSHDC), College of Hu-
man Sciences (CHS), University of South Africa
(UNISA). Prior to the commencement of data collection,
the final version of the study protocol, together with the
UNISA ethical clearance, was submitted to the Amhara
Regional State Health Bureau, Research and Technology
Transfer Core Process. Permission to conduct the re-
search was obtained from the local Institution Review
Board (IRB). In addition, a support letter was received
from the West Gojjam zone Health Department. Con-
sent to audit clinical records of randomly selected pa-
tients’ medical records was obtained from the heads or
owners of all 11 medium clinics. To maintain the confi-
dentiality of collected data, anonymity was maintained
throughout the research process.
Operational definitions
Uncomplicated malaria is defined as “a patient who
presents with symptoms of malaria and a positive para-
sitological test (microscopy or RDT), but with no fea-
tures of severe malaria” [7]. However, according to the
Ethiopian national guidelines, presumed malaria cases
can be identified in the absence of parasitological tests
and parasitological negative result patients investigated
for other causes of fever or managed through commu-
nity case management (CCM) principles [11].
Medium clinic is the next level of health care to pri-
mary level in the health system providing ambulatory
private health care that provides mainly curative, pre-
ventive and promotive services. According to the Ethiop-
ian national minimum standards [23], a medium private
clinic should be directed by a general practitioner with 3
years of relevant experience or by a public health officer
or by a nursing practitioner with Bachelor of Science
and who has 5 years of experience. To run a functional
clinic, a minimum of six additional health personnel
should be available in a single facility. The additional
health personnel would commonly include 2 diploma
nurses, 2 laboratory technicians, 1 radiographer and 1
midwife (optional).
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Ideal malaria diagnosis
In accordance with the National Malaria Guidelines
(2012), any adult patient suspect of malaria who is seen
at a health facility should be tested for malaria parasites
using thick & thin blood film, stained with 10% Giemsa
for 15 min. The film would then be screened under an
oil immersion microscope for the presence of Plasmo-
dium spp., and parasite density would be determined as
the number of parasites relative to the patient’s actual
red cell count. If this is not available, an average red cell
count of 5,000,000/μL of blood can be assumed in an
ideal malaria diagnosis [7, 8, 11, 24–26].
Acceptable malaria diagnoses
In the absence of a quality-assured malaria microscopy
test, any adult malaria suspect patient would require
testing with a malaria antigen test kit, which is a lateral
flow immunochromatographic antigen detection test
using finger-prick blood for rapid assay. Using this kit
provides a rapid qualitative and differential test for detection
of histidine rich protein-2 (HRP-2) or Plasmodium lactate
dehydrogenase (pLDH) specific to P. falciparum and pan
specific to other Plasmodium species (P. vivax, Plasmodium
malariae or Plasmodium ovale). A unique positive HRP2 or
PfpLDH line represents a P. falciparum infection whereas a
unique panpLDH line indicates an infection with one or
more of the non-falciparum species. The presence of both
test lines indicates either an infection with P. falciparum or a
mixed infection with P. falciparum and one or more of the
non-falciparum species. In cases where the control line did
not appear, the results were interpreted as invalid and the
test repeated with a new device is an acceptable malaria
diagnosis [7, 8, 11, 24–26].
Minor error malaria diagnosis
An adult malaria suspect patient that is investigated using
only Giemsa-stained thick film and has an estimated para-
site density using semi quantitative + signs was catego-
rized as minor error malaria diagnosis [7, 8, 11, 24–26].
Major error malaria diagnosis
An adult malaria suspect patient that is not identified and
investigated for parasitological confirmation is considered
as major error malaria diagnosis [7, 8, 11, 24–26].
Ideal treatment
If an adult has uncomplicated malaria then presumed
malaria, P. falciparum and mixed (P. falciparum + P.
vivax) infection is treated with artemether-lumefantrine
(AL) at a total dose of 5–24mg/kg body weight (BW) of
artemether and 29–144mg/kg of lumefantrine plus a sin-
gle low dose (Sld) 0.25mg/kg BW of primaquine. Patients
with P. vivax infection are treated with chloroquine phos-
phate 25mg/kg BW in three divided doses [11]. In
Ethiopia, primaquine 0.25mg/kg bw/day for a 14-day
treatment for radical cure of P. vivax infection is recom-
mended only in malaria elimination targeted districts [11].
Acceptable treatment
Patients with presumed malaria that have P. falciparum or
P. vivax, or a mixed infection, treated with second-line
treatment recommended, AL or quinine for clinical mal-
aria for P. falciparum, or mixed infection (P. falciparum +
P. vivax), and chloroquine plus primaquine for P. vivax
infections, are considered as acceptable treatment [11].
Minor error treatment
This term applies to a P. falciparum malaria patient,
treated with either AL plus artemether injection, or to a
P. vivax malaria patient, treated with chloroquine and
artemether injection, or chloroquine and AL, or for both
infections first-line drugs plus antibiotics prescription
[11]. In addition, if the malaria patient risks to develop
severe forms of malaria, or if a life-threatening situation
is reduced, then the error which occurred only increases
the cost for unnecessary drugs used at outpatient mal-
aria management and was classified as minor error [27].
Major error treatment
This term applies to malaria patients with P. falciparum
or presumed malaria cases who are treated with only
chloroquine and prescribed monotherapy (artemether) for
P. falciparum, P. vivax, mixed or presumed cases [11]. In
addition, if the risk for the malaria patient to develop se-
vere forms of malaria or life-threatening situations is high,
or treating malaria patients with monotherapy observed,
then the error which occurred in outpatient malaria man-
agement was classified as major error [27].
Results
General characteristics of patients
In the 3 months that preceded this study, 1650 cases of
suspected malaria were recorded in the outpatient facil-
ities of the 11 medium clinics. Medical or clinical records
were audited in respect of 330 adult patients who had
been diagnosed with and treated for uncomplicated mal-
aria. In addition, 61 clinical records (33 severe & compli-
cated malaria; 28 malaria co-morbidity with other ill
health conditions) were dropped from analysis. The mean
age with standard deviation (± SD) of the assessed adult
uncomplicated malaria patients was 29.9 (± 12.2) years.
Their median age was 26 years and the age range was 63
(81–18) years. A total of 40.6% (n = 134) of the adult pa-
tients fell into the age category range 21 to 30 years. More
than half (57.6%; n = 190) of the outpatient malaria service
beneficiaries were males. More than half (55.2%) of the
adult patients were from urban areas (Table 1).
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Clinical history and physical examination
A review of the patient files revealed that chief com-
plaints, detailed history of present illness and focused
physical examinations had been well documented in
91.2, 88.1 and 95.2% of cases, respectively (Table 2). His-
tory of fever during the previous 2 days, feeling hot dur-
ing physical examination or a temperature measurement
> 37.5 °C was the most common (89.1%) clinical feature
documented in the medical records of 294/330 selected
uncomplicated malaria patients. Chills and rigor (82.1%)
represented the second most common clinical feature
and headache (75.1%) was the third most prevalent clin-
ical feature (Fig. 2).
Diagnosis methods and results
This clinical audit also revealed that in 23.7% (391/1650)
of suspected cases, malaria had been diagnosed. How-
ever, 3.69 (61/1650) medical records of severe and com-
plicated malaria cases were excluded from further
evaluation. The majority of malaria cases (83.0%; 274/
330) had been confirmed by parasitological diagnosis, ei-
ther by microscope or by malaria RDT. However, among
parasitological negative patients, slightly less than one-
fifth (17.0%;56/330) of adults with uncomplicated mal-
aria had been diagnosed clinically after ruling out other
causes of fever. In this study, all malaria species identifi-
cation and parasite load estimation were made based on
thick blood films.
Laboratory investigations
It was found in the study that laboratory tests had been re-
quested for all 1650 adult cases of suspected malaria.
Blood tests for malaria using microscopy had been re-
quested for the majority (80.6%; 1330/1650) of cases. On
the other hand, one-fifth of cases (19.4%; 320/1650) had
been investigated using malaria RDTs that is acceptable
malaria diagnosis method, this performance does not
show statistical difference by partnership status of targeted
facility with 176/907 in PPP; and 144/743 in NPPP, X2
(1) = 0.0). The majority (80.6%; 1330/1650) of malaria sus-
pected patients investigated for malaria diagnosis using
only thick blood film was categorized as minor error diag-
nosis, this performance does not reveal statistical differ-
ence by partnership status with 170/1010 in PPP, and 80/
320 in NPPP; X2 (1) = 1.92, P = 0.16). Moreover, no
clinical records were found without investigation which
fulfil the sign and symptoms to suspect malaria which
were categorized as major error in malaria diagnosis.
The malaria parasite positivity rate was 20.3% (335/1650).
Out of 222 microscopy-diagnosed malaria cases 117
Table 1 Demographic characteristics of uncomplicated malaria patient of the reviewed clinical records Oct- 2016- Jan 2017
Characteristics Responses Frequency Percent
Age in categories 18–20 Years 89 27.0%
21–30 Years 134 40.6%
31–40 Years 48 14.5%
41–50 Years 37 11.2%
51 + Years 22 6.7%
Total 330 100.0%
Mean (± SD): 29.9 (± 12.2)Years; Median: 26 Years; Range: 63 (81–18) Years
Sex Male 190 57.6%
Female 140 42.4%
Total 330 100.0%
Patient evaluated by partnership status (n = 11 facility) PPP for malaria facilities 180 54.5%
Non PPP for malaria facilities 150 45.5%
Total 330 100.0%
Residence Urban 182 55.2%
Rural 148 44.8%
Total 330 100.0%
District / Woreda Bure 60 18.2%
Jabih Tehina 60 18.2%
Wonberma 90 27.3%
Finote Selam 120 36.4%
Total 330 100.0%
The table depicts the socio-demographic characteristics of selected patients
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(53.0%), 67(30%) and 38(17.0%) had been due to P. falcip-
arum, P. vivax, and mixed P. falciparum plus P. vivax infec-
tions, respectively. Looking at the 52 malaria RDT
diagnosed cases, 26 (50.0%), 15 (29.0%) and 11(21.0%) had
been due to P. falciparum, P. vivax, and mixed P. falcip-
arum plus P. vivax infections, respectively (Table 2).
Malaria case management
It was found in the study that the majority (82.9%; 68/
82) of adult uncomplicated Plasmodium vivax malaria
cases had received ideal treatment as per the standard
recommendation using chloroquine phosphate 25 mg/kg
BW in three divided doses (Table 3). This treatment
regimen does not have significant differences (i.e. PPP:
82.2%; 37/45; and NPPP: 83.8%; 31/37) in adherence of
national malaria standards by partnership status of en-
rolled private health facilities at X2 = 0.14; P-value = 0.70.
However, not all P. falciparum or mixed (P. falciparum
plus P. vivax) malaria cases had been treated with the
ideal recommendation. Accordingly, the audit revealed
that only one-fifth (20.6%; 68/330) of adult patients who
had been treated for malaria had received the ideal rec-
ommended treatment.
Approximately one-third (34.5%; 114/330) of patients
had received second-line treatment using AL or quinine
or chloroquine plus primaquine for P. falciparum, P. vivax
or mixed infections. These prescription and practices were
classified as acceptable treatment. This treatment regimen
does not have significant differences (i.e. PPP: 32.8%; 58/
180; and NPPP: 37.3%; 56/150) in adherence of national
malaria standards by partnership status of enrolled private
health facilities at X2 = 0.35; P-value = 0.55 (Table 4).
This study showed that 13.9% (46/330) of adult patients
had received AL plus an artemether injection, or chloroquine
plus an artemether injection or AL, or chloroquine plus anti-
biotics (i.e. tetracycline, doxycycline, metronidazole, clari-
thromycin, cefotaxime) or AL plus chloroquine (Fig. 3).
These treatment regimens fell in the “minor errors” category.
This treatment regimen does not have significant differences
(i.e. PPP: 13.3%; 24/180; and NPPP: 14.7%; 22/150) in adher-
ence of national malaria standards by partnership status of
enrolled private health facilities at X2 = 0.12; P-value =0.72.
Table 2 Uncomplicated malaria patients’ clinical records and laboratory investigation, Oct 2016 – Jan 2017
Characteristics Responses Frequency Percent
Chief compliant Yes 301 91.2%
No 29 8.7%
Comprehensive history Yes 291 88.2%
No 39 11.8%
Physical Examination Yes 314 95.2%
No 16 4.8%
Diagnosis methods (n = 330) Blood Film (microscopy) 222 67.0%
Rapid Diagnostic Tests (RDTs) 52 16.0%
Presumed Diagnosis (Sign & Symptom)a 56 17.0%
Microscopy diagnosis results (n = 222) P. falciparum 117 53.0%
P. vivax 67 30.0%
Mixed (P. falciparum & P. vivax) 38 17.0%
Rapid Diagnostic Tests results (n = 52) P. falciparum 26 50.0%
P. vivax 15 29.0%
Mixed (P. falciparum or both P. f and P. v) 11 21.0%




Hemoglobin Yes 254 76.9%
No 76 23.1%
Urine analysis Yes 182 55.2%
No 148 44.8%
The table presents the frequency of records of clinical and laboratory investigations of adult uncomplicated malaria patients
aFifty six patients were diagnosed for malaria based on evidences of signs & symptoms after having a negative reported result for parasitological tests
bSimple plus system method for estimating parasite load: + − 1- 10 parasites per 100 thick-film fields; ++: 11–100 parasites per 100 thick-film fields; +++: - 1- 10
parasites per thick-film field; ++++: more than 10 parasites per thick-film field [28]
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Finally, slightly less than one-third of the reviewed medical
records (30.9%; 102/330) indicated a diagnosis of P. falcip-
arum or clinical malaria, where patients had been treated
with chloroquine, or only using a mono-therapy prescription
with an artemether injection. These practices were catego-
rized under the “major errors” category. This treatment regi-
men does not have significant differences (i.e. PPP: 33.9%;
61/180; and NPPP: 27.3%; 41/150) in adherence of national
malaria standards by partnership status of enrolled private
health facilities at X2 = 1.16; P-value = 0.28 (Table 5).
Discussion
Sarkar and Seshadri [20] describe clinical records review
as a process that is aimed at obtaining retrospective data
to answer clinical queries. They also state that this
process has other known names such as ‘retrospective
data analysis’, ‘clinical chart review’ and ‘chart review.
Regular clinical audits provide a method for systematic-
ally reflecting on and reviewing practices. Changes can
be implemented at an individual, team or service level
[29]. This clinical audit revealed the current uncompli-
cated malaria case management practices in outpatient
facilities of 11 medium private clinics in the 3 months
that preceded the audit, that is, October 2016 –January
2017, in the West Gojjam Zone of the Amhara region,
Northwest Ethiopia.
In this study, the general information of patients, evi-
dence which includes initial or follow-up visit, age, blood
pressure, pulse, dark colour of urine, generalized weakness
(prostration) and jaundice, creatinine, and haemoglobin or
haematocrit laboratory results from investigations were
used to classify malaria cases as uncomplicated or severe
and complicated. These criteria are in line with national
and international classification either as uncomplicated or
severe and complicated malaria cases [7, 8, 10].
In this study, history of fever 2 days prior to examin-
ation, feeling hot during examination or a measured
temperature above 37.5 °C was recorded in the majority
of cases of patients diagnosed with and treated for mal-
aria. The most common clinical features like headache,
chills, shivering, joint pain, backache and anaemia were
checked, indicating that the high malaria investigation
rate was optimal. In contrast with this finding,
Meremikwu et al. [30] documented poor clinical records
by private practitioners in Nigeria. However, this finding
is consistent with evidence of improvement in the qual-
ity of public health services in the private sector through
exercising public private partnership approaches as pre-
sented by Basu et al. [31], and Yimer and Yalew [18].
The malaria parasite positivity rate was 23.7% (391/
1650). This finding is slightly lower than the four-year
retrospective data analysis report by Argaw et al. [19] of
a 24.5% malaria parasite positivity rate from 2959 facil-
ities/month data; Legesse et al. [32] reported an average
33.3% malaria parasite positivity rate from 5 years health
facility data; and Argaw [33] found a malaria parasite
Fig. 2 Bar chart showing proportion of clinical features, West Gojjam (n = 330), Oct 2016- Jan 2017. The figure depicts the frequency distribution
of clinical features as documented in patients’ medical records
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positivity rate of 37.6%. Despite diagnosing malaria using
only thick film, the result of malaria EQA for 31 public
private mix partnership engaged facilities score a con-
cordance rate of 94% through regional research and a la-
boratory centres expert [34]. Therefore, the laboratory
result is reliable. The difference might be explained by
the differences in the study periods and study areas.
The audit documented that the majority of adults with
malaria had been treated after parasitological confirmation
through microscopy or RDTs, which was in line with the
national and international recommendations. However,
only one fifth of malaria patients had received ideal anti-
malarial prescriptions in line with the national and inter-
national recommendations [7, 8]. Adherence of ideal
treatment does not show significant difference by public
private partnership status. This finding might have oc-
curred due to lack of uninterrupted supplies, and regular
technical support by the regulating bodies. However, Basu
et al. (2012) attribute the poor quality of work in the for-
mal private sector in part to perceived incentives linked to
unnecessary testing and treatment [31]. The result from
this study also reinforces the finding that there is room for
improvement regarding the efficient and effective use of
antimalarial drugs and supplies in the private sector.
In all 11 private health facilities enrolled in the study,
relative parasite load counts were used. This semi-
quantitative method of quantifying using “+” signs is rec-
ommended by WHO (1991) for use only when it is not
possible to undertake a parasite count per microlitre of
blood [24]. This finding may be explained by lack of la-
boratory supply, that is, absolute methanol or ethanol to
fix the thin blood film, as the parasite load result re-
ported by all private health facilities employ were using
only thick blood film smears. However, the WHO
(2015), in the third edition of its guidelines for the treat-
ment of malaria, discourages this method of parasite
Table 3 Anti-malarial prescription with ideal prescription or treatment classifications, West Gojjam, Oct 2016 – Jan 2017
Description Ideal Treatment
AL+ sld PQ Chloroquine 25 mg/kg bw Over all










PPM NPPM Both PPM
+NPPM
PPM NPPM
Microscopy (n = 252)
P. falciparum 117 63 54 0 0 0 NA NA NA NA NA NA 117 0 0.0
Mixed (Pf
&Pv)
38 23 15 0 0 0 NA NA NA NA NA NA 38 0 0.0
Presumedb 30 12 18 0 0 0 NA NA NA NA NA NA 30 0 0.0
P. vivax NA NA NA NA NA NA 67 34 33 57 29 28 67 57 85.1
Sub total 185 98 87 0 0 0 67 34 33 57 29 28 252 57 22.6
Percentage
0.00 0.00 0.00 85.1 85.2 84.8 22.6
RDTs (n = 78)
P. falciparum 26 16 10 0 0 0 NA NA NA NA NA NA 26 0 0.0
Mixed (Pf
&Pv or Pf)
11 7 4 0 0 0 NA NA NA NA NA NA 11 0 0.0
Presumedb 26 14 12 0 0 0 NA NA NA NA NA NA 26 0 0.0
P. vivax NA NA NA NA NA NA 15 11 4 11 8 3 15 11 73.3
Sub total 63 37 26 0 0 0 15 11 4 11 8 3 78 11 14.1
Percentage
0.00 0.00 0.00 73.3 72.7 75.0
Grand
total
248 135 113 0 0 0 82 45 37 68 37 31 330 68 20.6
Percentage
0.00 0.00 0.00 82.9 82.2a 83.8a 20.1
The table depicts the frequency of records of antimalarial drug prescription in 11 medium clinics in the West Gojjam Zone, Amhara. It also describes the ideal
prescription or treatment practices by partnership status
aThe X2 statistic is 0.14. The p-value is .70. This result is not significant at p < .05. Ideal treatment for Pf, Pf or Mixed & presumed malaria with AL plus Sld PQ was
Zero; ideal treatment for Pv with CQ was 82.9% (68/82) and over all ideal treatment proportion was 20.6% (68/330). bnegative microscopy or RDT result but
treated as presumed malaria cases
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load estimation [7]. Moreover, thick blood film is recom-
mended for screening suspected cases of malaria, while
thin blood film is to be used to identify species of Plas-
modium parasites, quantify proportion of parasitized red
blood cells, perform platelets count and study blood cells
morphology [25, 35].
In Ethiopia, the two most dominant malaria parasites
are P. falciparum and P. vivax [3]. In this audit, slightly
more than half (52%) of the parasitologically confirmed
cases were caused by P. falciparum, close to one-fifth
(17.8%) of the malaria cases were caused by mixed (P. fal-
ciparum plus P. vivax) infections, while the rest (30.0%)
were caused by P. vivax. This finding is in line with pro-
portions of reported malaria species. A nationwide facility
retrospective report by Argaw et al. [19] indicates that
50.4, 45.6 and 4.1% of confirmed malaria cases were
caused by P. falciparum, P. vivax and mixed infection, re-
spectively. In addition, these figures were consistent with
the report of the Ethiopia malaria indicator survey (EMIS),
in which P. falciparum is reported to account for 77%
(MIS 2011) [36] and 87.9% (EMIS 2015) [12] of the total
reported malaria cases. The difference in figures might be
explained by the reporting of P. falciparum cases only, or
P. falciparum as mixed cases [3, 12, 37, 38].
In this study, no malaria patients were investigated
with ideal malaria diagnosis methods recommended by
WHO [25]. This could be occurred due to lack of la-
boratory supplies like absolute methanol or ethanol and
the laboratory staff may not be motivated to engaged in
demanding and time-consuming activities due to high
workload. In addition, close to one fifth of uncomplicate
malaria cases were investigated with acceptable malaria
diagnosis method. Though this was helpful to improve
species specific management, has some limitation on
quantification of parasite density. The majority 80.6% of
malaria patients were investigated using thick film which
is reliable on screening and accepting negative results.
Species identification and quantification of parasite load
determines classification of patients as uncomplicated
and severe life-threatening malaria cases [39]. Hence, it
also reflects on evidence-based decision making on mal-
aria patient management.
Fig. 3 Clinical record audited against the standard malaria algorism, West Gojjam, Ethiopia, Oct 2016- Jan 2017. The figure summarize the
findings of clinical record audited against the standard malaria diagnosis and treatment guidelines
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Most adults were treated for a parasitologically con-
firmed malaria diagnosis and only 82.9% P. vivax malaria
patients received the ideal treatment. However, not all P.
falciparum, mixed and presumed malaria patients were
treated based on the recommended treatment regimen of
the recently revised national malaria guidelines of
Ethiopia, which is AL plus SLD primaquine. Furthermore,
slightly less than one-fifth of presumed malaria patients
were diagnosed and received treatment after negative la-
boratory test results had been documented. This finding is
in line with Argaw’s [33] finding that the national survey
revealed that health workers adhered to standard recom-
mendations with respect to less than half of malaria pa-
tients they encountered. This could partly be due to
insistence and pressure from patients to get anti-malaria
drugs for febrile illnesses, providers’ clinical beliefs and
capacity constraints of health providers to look for other
causes of fever, limited patient diagnosis services and
practices to identify other aetiologies such as viruses at
medium clinics [28, 40, 41].
Despite these deviations from national and inter-
national recommendations, more than one third of
Ethiopian mothers preferred to visit private sector fa-
cilities for their perceived responsiveness than public
sector ones. This finding was in line with the Awoke
et al. [42] report on perceived better responsiveness
of the private sector compared to the public sector in
Ghana. Figure 4 depicts the comparative achievements
by partnership status. More patients were given the
ideal treatment, fewer second-line drugs were pre-
scribed and there were fewer minor errors in PPP fa-
cilities than in non-PPP facilities. This finding was
not consistent with the findings of [29, 43–45], who
also documented evidence of improvement in quality
achieved through working in various modalities of
partnerships.
These major deviations from both national and inter-
national recommendations need intervention by both
the private and the public sector, otherwise the poor
quality of care documented in the private sector will
contribute to drug resistance and loss of resources [17].
This finding is not in line with the standard recommen-
dation on the management of uncomplicated malaria pa-
tients based on identified species.
Table 4 Anti-malarial prescription with acceptable and minor error treatment classifications, West Gojjam, Oct 2016 – Jan 2017
Description Acceptable & Minor Error Treatments
Illegible Acceptable treatment (AL or Qn Or CQ + 14 d PQ) Minor Error (AL + Arth or Antib Or CQ + Arth or Antib
Actual practices Actual practices
Both PPM + NPPM PPM NPPM Both PPM + NPPM PPM NPPM Both PPM + NPPM PPM NPPM
Microscopy (n = 252)
P. falciparum 117 63 54 62 28 34 3 2 1
Mixed (Pf &Pv) 38 23 15 4 4 0 34 19 15
Presumeda 30 12 18 11 5 6 0 0 0
P. vivax 67 34 33 3 1 2 5 2 3
Sub total 252 132 120 80 38 42 42 23 19
Percentage 31.7 28.8 31.8 16.7 17.4 15.8
RDTs (n = 78)
P. falciparum 26 16 10 13 9 4 0 0 0
Mixed (Pf &Pv or Pf) 11 7 4 10 6 4 1 1 0
Presumeda 26 14 12 11 5 6 2 0 2
P. vivax 15 11 4 0 0 0 1 0 1
Sub total 78 48 30 34 20 14 4 1 3
Percentage 43.6 41.6 46.6 5.1 2.1 10.0
Grand total 330 180 150 114 58 56 46 24 22
Percentage 34.5 32.8b 37.3b 13.9 13.3% c 14.7%c
The table depicts the frequency of records of antimalarial drug prescription in 11 medium clinics in the West Gojjam Zone, Amhara. It also describes the
magnitude of acceptable prescription or treatment practices by partnership status. In addition, it describes the frequency of minor errors treatment practices by
partnership status
AL Artemether –Lumefantrine, PQ Premaquine, CQ Chloroquine, Qn Quinine, sld Single low dose, Arthem Arthemter injection, Antibio Antibiotics, a: negative
microscopy or RDT result but treated as presumed malaria cases; Acceptable Treatments: AL or Quinine for Pf malaria cases 75 patients; AL or Quinine for Mixed
(Pf or Pf & Pv) malaria cases 14 patients; AL or CQ plus PQ for 14 days for 3 patients; Presumed malaria cases treated with Qn or AL for 14 patients. Minor Error
treatment: AL plus Arthem Injection for 3 Pf malaria cases; CQ plus Arthem Injection for 6 Pv malaria case; AL plus Arthem plus Tetracycline or Metronidazole or
Doxycycline 35 mixed (Pf & Pv) malaria cases; AL plus Arthem Injection for 2 Presumed malaria cases
bThe X2 statistic is 0.35. The p-value is 0.55. This result is not significant at p < .05
cThe X2 statistic is 0.12. The p-value is 0.72. This result is not significant at p < .05
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Fig. 4 Radar chart showing the adherence to malaria treatment by partnership status, West Gojjam Zone, Amhara, Ethiopia, Oct 2016- Jan 2017.
The chart depicts the comparative compliance with national and international guidelines by partnership status
Table 5 Anti-malarial prescription with major error classifications, West Gojjam, Oct 2016 – Jan 2017
Description Major error Treatment
Major Error (CQ for Presumed Malaria Or Monotherapy with Arthem injection for Pf or Pv or mixed malaria cases)
Illegible Actual practices
Both PPM + NPPM PPM NPPM Both PPM + NPPM PPM NPPM
Microscopy (n = 252)
P. falciparum 117 63 54 52 33a 19a
Mixed (Pf &Pv) 38 23 15 0 0 0
Presumedd 30 12 18 19 7b 12b
P. vivax 67 34 33 2 2a 0
Sub total 252 132 120 73 42 31
Percentage 28.9 31.8 25.8
RDTs (n = 78)
P. falciparum 26 16 10 13 7a 6a
Mixed (Pf &Pv or Pf) 11 7 4 0 0 0
Presumedd 26 14 12 13 9b 4b
P. vivax 15 11 4 3 3a 0
Sub total 78 48 30 29 19 10
Percentage 37.2 39.6 33.3
Grand total 330 180 150 102 61 41
Percentage 30.9 33.9c 27.3c
The table depicts the frequency of records of antimalarial drug prescription in 11 medium clinics in the West Gojjam Zone, Amhara. The table presents the
magnitude of major errors by partnership status
a70 Pf or Pv malaria patients were treated with only Arthem Injection;
b 32 dPresumed malaria patients were treated with CQ;
cThe X2 statistic is 1.16. The p-value is 0.28. This result is not significant at p < .05; Major Error Treatment
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Limitations
This clinical audit was performed using retrospective
data; as a result, there was a higher risk of getting in-
complete and inconsistent data. In addition, it is impera-
tive to consider the small sample size before interpreting
and inferring the result of this study; the exclusion of pa-
tients age less than 18 years, diagnosed with severe and
complicated malaria, and co-infected with other diseases
may reduce the estimation on prevalence and species.
Conclusions
The clinical audit revealed that the majority of malaria pa-
tients had received malaria diagnostic services with minor
errors. In addition, only one fifth of malaria patients had
received ‘ideal’ malaria treatment services. Therefore, ef-
forts should be made to improve access to antimalarial
supplies including absolute methanol, Primaquine and
AL. In addition, enhancing the diagnosis and management
capacity of healthcare providers though supervision and
technical support are recommended. Finally, to under-
stand the reasons for the low levels of malaria diagnosis
and treatment adherence with national guidelines, a quali-
tative exploratory descriptive study is recommended.
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